|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Discovery of a potent inhibitor of the antiapoptotic protein Bcl-x(L) from NMR and parallel synthesis显示文摘 | Petros A M Dinges J Augeri D J | 2006 | J MedChem2006，49，： | 1 |
| 2 | Discovery of a potent inhibitor of the antiapoptotic protein Bcl-xL from NMR and parallel synthesis 显示文摘 | Petros AM Dinges J Augeri DJ | 2006 | J Med Chem2006，49，2： | 1 |
| 3 | Longterm treat with allergic immunotherapy with parietaria clinical and immunologic effects in a randomized controlled trial显示文摘 | ARIANO R KROON A M AUGERI G | 1999 | Allergy1999，54，： | 1 |
| 4 | Discovery of a potent inhibitor of the antiapoptotic protein Bcl-xL from NMR and parallel synthesis 显示文摘 | Petros A M Dinges J Augeri D J | 2006 | J Med Chem2006，49，2： | 1 |
| 5 | Effect of short-term treatment with low dosages of the proton-pump inhibitor omeprazole on serum chromogranin A levels in man显示文摘 | Giusti M Sidoti M Augeri C | 2004 | Eur J Endocrinol2004，150，3： | 1 |
| 6 | Discoveryand preclinical profile of saxagliptin ( BMS-477118) : A highly po-tent, long-acting, orally active dipeptidyl peptidase IV inhibitorfor the treatment of type 2 diabetes 显示文摘 | AUGERI D J ROBL J A BETEBENNER D A | 2005 | J Med Chem2005，48，15： | 1 |
| 7 | Disco-very of a potent inhibitor of the antiapoptofic protein Bcl-XL from NMR and parallel synthesis显示文摘 | PETROS A M DINGES J AUGERI D J | 2006 | J Med Chem2006，49，2： | 1 |
| 8 | Long-term treatment with allergoid immunotherapy with parietaria chinical and immunologic effect in a randomized, controlled trial 显示文摘 | Ariano R Krooom AM Augeri G | 1999 | Allergy1999，54，4： | 1 |
| 9 | Discovery of a potent inhibitor of the an tiapoptotic protein Bcl-XL from NMR and paralle 1 synthesis显示文摘 | Petros AM Dinges J Augeri DJ | 2006 | J Med Chem2006，49，： | 1 |
| 10 | Discovery of a potent inhibitor of the antiapoptotie protein Bcl-xL from NMR and parallel synthesis显示文摘 | Petros A M Dinges J Augeri D J | 2006 | J Med Chem2006，49，2： | 1 |
| 11 | Effect of short-term treatment with low dosages of the proton-pump inhibitor omeprazole on serum chromogranin A levels in man 显示文摘 | Giusti M Sidoti M Augeri C | 2004 | Eur J Endocrinol2004，150，： | 1 |
| 12 | Discovery and preclinical profile of saxagliptin(BMS-477118):a highly potent,long-acting,orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes显示文摘 | Augeri D J Robl J A Betebenner D A | 2005 | J Med Chem2005，48，15： | 1 |
| 13 | Discovery and preclinical profile of Saxagliptin (BMS-477118): a highly potent, long-acting, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes显示文摘 | Augeri D J Robl JA Betebenner DA | 2005 | J Med Chem2005，48，15： | 1 |
| 14 | Discovery and preclinical profile of saxagliptin (BMS-477118):a highly potent,long-acting,orally active dipeptidyl peptidase Ⅳ inhibitor for the treatment of type 2 diabetes显示文摘 | Augeri D J Robl J A Betebenner D A | | 0，，15： | 1 |
| 15 | Discovery and preclinicalprofile of Saxagliptin(BMS-477118): a highly potent, long-acting, orallyactive dipeptidyl peptidase IV inhibitor for the treatment of type 2diabetes显示文摘 | Augeri DJ Robl JA Betebenner DA | 2005 | Journal of Medicinal Chemistry2005，48，15： | 1 |
| 16 | Discovery and preclinical profile of Saxagliptin (BMS-477118) : a highly potent, long-acting, orally active dipeptidyl peptidase Ⅳ inhibitor for the treatment of type 2 diabetes显示文摘 | AUGERI DJ ROBL JA BETEBENNER DA | 2005 | J Med Chem2005，48，15： | 1 |
| 17 | Discovery and preclinical profile of Saxagliptin(BMS-477118):a highly potent,long-acting,orally active dipeptidy1 peptidase IV inhibitor for the treatment of type 2 diabetes显示文摘 | AUGERI DJ ROBL JA BETEBENNER DA | 2005 | J Med Chem2005，48，15： | 1 |
| 18 | Discovery and pre-clinical profile of saxagliptin (BMS-477118):a highly potent,long-acting,orally active dipeptidyl peptidaseIVinhibitor for the treatment of type 2 diabetes 显示文摘 | Augeri DJ Robl JA Betebenner DA | 2005 | J Med Chem2005，48，15： | 1 |
| 19 | Discovery and preclinical profile of saxagliptin (BMS-477118): a highly potent, long-acting, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes显示文摘 | Augeri DJ Robl JA Betebenner DA | 2005 | J Med Chem2005，48，15： | 1 |
| 20 | An inhibitor of Bcl-2 family proteins induces regression of solid tumours显示文摘 | Oltersdorf T Elmore S W Shoemaker A R Armstrong R C Augeri D J Belli B A | 2005 | Nature2005，435，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员